ELAVAY Research
The syndicated platform for Advocacy Intelligence, showing where you lead, where gaps remain, and where to act.
- Benchmark and disease-state reports
- Health equity, SDOH, and policy pulse
- BioAdvocate Benchmark and custom studies
We give advocacy leaders inside pharma and biotech the research, benchmarks, and training to turn what patients say into programs their organization will fund.
Strategic insight, internal influence, patient trust, and business impact. Each one strengthens your case in the room where budgets get set.
Decision-ready Advocacy Intelligence, not surface-level feedback.
Tools that move findings into funded, leadership-backed action.
Engagement that protects and strengthens community credibility.
Advocacy positioned as an enterprise strategy function.
Answer twenty questions. Discover which of four advocacy archetypes you are today, and the path to the next.
Capture ground-level signal from patients, advocates, and community leaders.
Translate Advocacy Intelligence into priorities leadership can act on.
Connect findings to business priorities, internal teams, and customers.
Move from research to funded action with 6 or 12 months of activation support.
Every engagement begins and ends with what patients truly need.
The syndicated platform for Advocacy Intelligence, showing where you lead, where gaps remain, and where to act.
Strategic counsel that turns intelligence into internal influence before every critical inflection point.
Equip teams to engage advocacy organizations with credibility, and prove the value of advocacy internally.
Rigorous research meets lived patient experience, and a willingness to say what others won’t.
Data and insights translated into strategic action leadership will fund, trust, and use. Not another report that sits on a shelf.
Industry strategy and personal patient experience in one partner. Advocacy fluency you cannot fake.
Direct counsel that challenges complacency and protects the trust of the patient community above all.
Broad cross-therapeutic insight while preserving disease-specific nuance.
Trend lines that turn resource conversations into evidence-led decisions.
Advisory guidance that helps findings become internal influence.
June turned a year of deferred accountability into a month of consequences, and for once the pressure landed on the players who profit instead of the patients who pay.
Four distinct kinds of patient support exist. Knowing the difference helps you find the right help faster.
Six practical steps to narrow down thousands of advocacy organizations to the ones that will actually help you.
The ELAVAY Survey was the foundation of our continued defense as the industry's number one patient advocacy function for over ten years.
Backed by ELAVAY Advocacy Intelligence reporting since 2015.
Their work helped our team rethink how we engage and learn from patients.
Whether you are exploring research, an advisory session, or team training, we would love to learn more about your goals.